Table 3 The overall survival and recurrence free survival on multivariate analyses
From: suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma
Overall Survival | |||
Variable | Odds ratio | 95% CI | P value |
suPARnostic | 5.1845 | 1.4987 to 17.9356 | 0.0094* |
CCI | 2.742 | 1.3821 to 5.4397 | 0.0039* |
Age | 1.0657 | 0.9861 to 1.1517 | 0.1083 |
Symptomatic at diagnosis | 0.4789 | 0.1390 to 1.6499 | 0.2434 |
Type of Treatment | 0.3538 | 0.0737 to 1.6993 | 0.1944 |
Male gender | 2.4869 | 0.7034 to 8.7927 | 0.1574 |
T-stage | 2.6858 | 1.1148 to 6.4705 | 0.0276 |
Fuhrman grade | 3.4722 | 0.9586 to 12.5772 | 0.058 |
Recurrence Free Survival | |||
suPARnostic | 2.2864 | 1.0156 to 5.1470 | 0.0458* |
T-stage | 2.0156 | 1.2284 to 3.3073 | 0.0055* |
Fuhrman grade | 1.189 | 0.7137 to 1.9808 | 0.5063 |
Type of Treatment | 1.3676 | 0.5279 to 3.5430 | 0.5192 |
Male gender | 2.106 | 0.8447 to 5.2507 | 0.1101 |